Jaipur, June 15 (IANS) The Rajasthan government on Tuesday fixed the prices of the rapid antigen test for Covid at Rs 200 in all private labs and hospitals.In April, the state government reduced the cost of RT-PCR test from Rs 500 to Rs 350.According to the orders issued by the state Medical and Health Department on Tuesday, the rapid antigen test can be done at any private hospital or private lab now at Rs 200.The main objective of allowing this test to be conducted in a private lab at a fixed price is to bring quick and fast results, so that when the initial symptoms appear, the patient can be diagnosed and treated, it said. This test will be suitable for patients suffering from cold, cough and fever.--IANSarc/vd
Chennai, May 16 (IANS) A police team led by Adyar Deputy Commissioner arrested three persons for selling Remdesivir vials at higher price than its Maximum Retail Price (MRP) from Indira Nagar area here.The accused were identified as Adithyan, a medical salesman from KK Nagar, Rajkumar, who runs a pharmacy in Pattalam and Sajad Ahmad, who works in a medical shop at Thousand Lights.Police said that a special team of the police led by Sub-Inspector Selvakumar and constables Venkatesan and Shankar and other police officers received information that Remdesivir vials were being sold by some people at Rs 25,000 per vial, after contacting prospective clients online.The police team found Adithyan, Rajkumar and Sajad Ahmad standing suspiciously at Indira Nagar and on search recovered Remdesivir vials from the trio. Vials and Rs 89,000 in cash were recovered from them.Deputy Commissioner of Police, Adayar, Vikraman, told IANS said: "We suspect that the medicine was routed from Bangladesh through Tripura and we are investigating it."--IANSaal/sdr/
New Delhi, May 9 (IANS) Delhi would need 60 lakh doses of vaccine per month to vaccinate around 93 lakh people in the 18-45 age group during May to July, Chief Minister Arvind Kejriwal said on Sunday.In a letter to Union Health Minister Harsh Vardhan, he requested the Centre to direct the Serum Institute of India and Bharat Biotech to increase monthly supplies of Covid vaccines to Delhi to 60 lakh doses for the next three months."The Central government should make available to the state the requisite number of vaccines to enable vaccination of all citizens. The Centre should actively monitor and supervise the manufacture of vaccines by the private parties so that the supplies in adequate numbers are made to all state governments and this crucial aspect is not left to the direction of private manufacturers," he wrote in the letter.Kejriwal also said that states should be allowed to develop separate apps or mechanism for vaccination. He also demanded that a uniform price should be fixed for the vaccines for supplies made to the governments and private hospitals. "The inherent fallacy and danger in the current differential pricing mechanism is that there is an obvious incentive for private manufacturers to prioritise supply to private hospitals," he said."Delhi has a population of two crore, out of which 1.5 crore people are above the age of 18. Vaccinating all of them would mean 3 crore doses. We have received roughly 50 lakh doses so far. Therefore, we need additional 2.5 crore doses."As the third Covid wave is also anticipated soon, we want to complete vaccination of all people in Delhi within next three months. To complete it in three months, we would need 23 lakh doses per month from GOI channels during May to July."I urge you to direct Serum Institute of India and Bharat Biotech to increase monthly supplies to Delhi to 60 lakh doses during May to July," Kejriwal added.Meanwhile, Delhi vaccinated over 1.28 lakh people on Saturday, the state government said, adding that it currently has 4.65 lakh doses of coronavirus vaccines available for those above 45, and healthcare and frontline workers, while 2.74 lakh doses are available for the 18-44 age category.Delhi has so far received 5.5 lakh doses of coronavirus vaccines for the 18-44 category, and over 43 lakh doses for 45-plus, and healthcare and frontline workers.--IANSpd/vd
New Delhi, May 9 (IANS) Amid calls for full exemption of goods and services tax (GST) on vaccines, Finance Minister Nirmala Sitharaman on Sunday said that a complete waiver may lead to a rise in their prices, impacting the common man.Responding to West Bengal Chief Minister Mamata Banerjee's letter to the Prime Minister seeking support to improve the health infrastructure, along with removal of GST and customs duty from life-saving drugs and equipment, Sitharaman noted that vaccine makers would not be beneficiaries of input tax credit in case GST is exempted.The Finance Minister was of the view that a "nominal 5 per cent GST is in the interest of the domestic manufacturer of vaccine and in the interest of the citizens"."If full exemption from GST is given, vaccine manufacturers would not be able to offset their input taxes and would pass them on to the end consumer/citizen by increasing the price," she said.The minister noted that GST at rates varying from 5 per cent on vaccines to 12 per cent on Covid drugs and oxygen concentrators is applicable to domestic supplies and commercial import of these items.If IGST of Rs 100 is collected on an item, Rs 50 accrues to the Centre and the states each as CGST and SGST, respectively. Further 41 per cent of the CGST revenue is devolved to states. So out of a collection of Rs 100, as much as Rs 70.50 is the states' share, she said in another tweet.She noted that Covid vaccines are being provided free of cost by the Centre to those who are 45 years of age and above and to all frontline workers and on government supplies, GST is also paid by the government.She also said that in order to augment the availability of these items, the government has also provided full exemption from basic customs duty and health cess to their commercial imports.--IANSrrb/sn/vd
Hyderabad, April 29 (IANS) Bharat Biotech on Thursday announced that it is slashing the price of its Covid-19 vaccine Covaxin to Rs 400, from Rs 600 earlier, for state governments.The announcement came a day after the Serum Institute of India (SII) cut the price of Covishield to Rs 300 from Rs 400 earlier.The two vaccine makers slashed the prices after the Central government reportedly made a request to them amid the row over different pricing for the Central and state governments.Bharat Biotech said in a statement on Thursday that it deeply concerned with the critical pandemic circumstances that India is facing at this time."Recognising the enormous challenges to the public healthcare system, we have made Covaxin available to state governments at a price of Rs 400 per dose," the Hyderabad-based company said."We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally-intensive BSL-3 manufacturing facilities (the first of its kind in our country) and clinical trials," it added.The company stated that for the last one year, Team Bharat Biotech has been fearlessly handling live SARS-CoV-2 virus strains, tirelessly working round-the-clock while overcoming many challenges given the uncertainty of the pandemic.Bharat Biotech had on April 24 announced the prices of Covaxin. It fixed at Rs 1,200 as the price per dose for private hospitals. This is twice the cost fixed by the SII for Covishield.For exports, it has priced India's first indigenous Covid vaccine at $15-$20 (Rs 1,125-1,500).Ever since the launch of Covid vaccination programme in India, Bharat Biotech and the SII have been supplying their vaccines to the Centre at Rs 150 per dose.While Bharat Biotech is likely to continue the supplies to the Centre at the same price, the SII had hinted at revising this to Rs 400.--IANSms/vd
Panaji, April 23 (IANS) The Goa government on Friday lowered the existing capped price for Covid-19 treatment in private hospitals from Rs 10,000 per day to Rs 8,000 per day for treatment in a general ward."Considering the sudden surge of Covid-19 cases in the state of Goa and in order to make private services more affordable to the common man during the Covid-19 crisis, government hereby reduces the capped rates prescribed," says an order issued by the Health Ministry.Prices for twin sharing rooms have been reduced from Rs 13,000 per day to Rs 10,400 per day, while the charges for treatment in private single rooms have been reduced from Rs 16,000 per day to Rs 12,800 per day.Treatment in an ICU facility with ventilators have also been slashed from Rs 24,000 per day to Rs 19,200 per day.The reduced rates do not include services like diagnostic interventions, use of special drugs and equipment, other surgical procedures and extra oxygen flow, the order also states.--IANSmaya/vd
Dear Patron, Please provide additional information to validate your profile and continue to participate in engagement activities and purchase medicine.